Autori: Stamatovic Ljiljana
| Naslov | Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer (Article) |
| Autori | Geyer Jr Charles E ... Stamatovic Ljiljana ... (broj koautora 34) |
| Info | NEW ENGLAND JOURNAL OF MEDICINE, (2025), vol. 392 br. 3, str. 249-257 |
| Projekat | F. Hoffmann-La Roche/Genentech |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer (Article; Early Access) |
| Autori | Geyer Jr Charles E ... Stamatovic Ljiljana ... (broj koautora 35) |
| Info | NEW ENGLAND JOURNAL OF MEDICINE, (2025), vol. br. , str. - |
| Projekat | F. Hoffmann-La Roche/Genentech |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Original Research Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study (Article) |
| Autori | O'Shaughnessy Joyce ... Cvetanovic Ana S ... Stamatovic Ljiljana |
| Info | EUROPEAN JOURNAL OF CANCER, (2021), vol. 152 br. , str. 223-232 |
| Projekat | F. Hoffmann-La Roche Ltd.Hoffmann-La Roche |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Patient (pt) preference for the pertuzumab-trastuzumab fixed-dose combination for subcutaneous use (PH FDC SC) in HER2-positive early breast cancer (EBC): Primary analysis of the open-label, randomised crossover PHranceSCa study (Meeting Abstract) |
| Autori | O'Shaughnessy Joyce ... Cvetanovic Ana S ... Stamatovic Ljiljana |
| Info | ANNALS OF ONCOLOGY, (2020), vol. 31 br. , Suppl. 4, str. S306-S307 |
| Projekat | F. Hoffmann-La Roche Ltd.Hoffmann-La Roche |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries (Review) |
| Autori | Belkacemi Yazid ... Tesanovic Dusanka D ... Popovic Lazar S ... Kovcin Vladimir N ... Dzodic Radan R Markovic Ivan Z Vasovic Suzana Stamatovic Ljiljana Radosavljevic Davorin Z Radulovic Sinisa S ... (broj koautora 48) |
| Info | EUROPEAN JOURNAL OF CANCER, (2020), vol. 135 br. , str. 130-146 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Patient (pt) preference and satisfaction with the subcutaneous fixed-dose combination of pertuzumab (P) and trastuzumab (H) in pts with HER2-positive early breast cancer (HER2+eBC): Interim analysis of the open-label, randomised cross-over PHranceSCa study (Meeting Abstract) |
| Autori | O'Shaughnessy Joyce ... Cvetanovic Ana S ... Stamatovic Ljiljana |
| Info | ANNALS OF ONCOLOGY, (2020), vol. 31 br. , Suppl. 2, str. S42-S42 |
| Projekat | F. Hoffman-La Roche |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer (Article) |
| Autori | Conte Pier Franco ... Stamatovic Ljiljana ... (broj koautora 21) |
| Info | CANCER, (2020), vol. 126 br. 13, str. 3132-3139 |
| Projekat | Roche HoldingGenentech |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan) (Article) |
| Autori | Todorovic Vladimir ... Babovic Nada Lj ... Cetnikovic Bojana Ceric Timur ... Dzamic Zoran M Dzodic Radan R Eri Zivka ... Knezevic-Usaj Slavica F Kovcin Vladimir N ... Markovic Ivan Z Markovic Milan Mijalkovic Nenad ... Pantelic Aleksandra Popovic Lazar S Radosavljevic Davorin Z ... Radulovic Sinisa S ... Rosic Ivana ... Stamatovic Ljiljana ... Tesanovic Dusanka D Tomasevic Zorica I Tomasevic Zoran M ... Vasovic Suzana Vicko Ferenc ... Zaric Bojan ... (broj koautora 65) |
| Info | JOURNAL OF BUON, (2019), vol. 24 br. 5, str. 2180-2197 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Patient-reported outcomes (PROs) from KATHERINE: A phase III study of adjuvant trastuzumab emtansine (T-DM1) versus trastuzumab (H) in patients (pts) with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer. (Meeting Abstract) |
| Autori | Schneeweiss Andreas ... Stamatovic Ljiljana ... (broj koautora 20) |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2019), vol. 37 br. 15, Suppl. S, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients (Article) |
| Autori | Stamatovic Ljiljana Susnjar Snezana V Gavrilovic Dusica Minic Ivana Z Ursulovic Tamara B Dzodic Radan R |
| Info | JOURNAL OF BUON, (2018), vol. 23 br. 5, str. 1273-1280 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
